Financial Data and Key Metrics Changes - The company reported Q4 sales of 223million,exceedingthehighendofguidance,representinga5867 million, slightly below the record set in 2023, marking the second-highest sales in company history [8] - Q4 net income was 34million,contributingtoafull−yearrecurringincomeof131 million, which indicates strong cash flow [11][12] - Gross margin for Q4 remained flat year-over-year at 37%, while operating margins were strong at 25% [20][21] - The total cash and short-term investments increased by 128millionto641 million, a 25% year-over-year growth [12][24] Business Line Data and Key Metrics Changes - IC revenue increased by 5% quarter-over-quarter, driven by a 21% surge in high-end sales, while mainstream demand saw a slight reduction [17][18] - FPD revenue improved by 7% sequentially, with strong mainstream growth, although high-end demand remained flat [19] - The strongest demand by node was for 22-28 nanometers and sub-14 nanometers, including specialty EUV business [18] Market Data and Key Metrics Changes - Demand for IC masks turned positive, particularly for high-end designs in Asia and the US, driven by VisionEdge AI chips [8][9] - The FPD mask demand is influenced by new designs and larger display sizes, particularly G10.5%+ panels [10] Company Strategy and Development Direction - The company plans to invest 200millioninCapExfor2025,focusingonexpandingICcapacityintheUSandaccommodatingregionalizationtrends[13][23]−Thecompanyaimstoleverageitscompetitiveadvantagesandmaintainitsmarket−leadingpositioninthephotomaskindustry[15][28]Management′sCommentsonOperatingEnvironmentandFutureOutlook−Managementexpressedoptimismaboutthephotomaskindustry′sgrowthtrajectory,drivenbyregionalization,AI,andadvancedsemiconductordesigns[41][43]−Thecompanyanticipatesfirst−quarterrevenuetobeintherangeof208 million to 216million,accountingfortypicalseasonality[27]OtherImportantInformation−Thecompanyauthorizedanincreaseinsharerepurchasefrom32 million to 100millionaspartofitscapitalallocationstrategy[25][26]−Totaldebtdecreasedby2718 million remaining, expected to be paid off at maturity [24][25] Q&A Session Summary Question: Increase in operating expenses - Operating expenses increased due to higher SG&A and R&D costs, with approximately half of the increase being non-recurring [34] Question: Details on R&D spending - R&D spending was driven by a robust pipeline of new projects, including a 7nm node optical project and EUV high-NA program [35][36] Question: CapEx for 2025 - Most of the $200 million CapEx is earmarked for new capacity, focusing on the US market, with expansions within existing sites [38] Question: Industry growth outlook - Management is optimistic about the photomask industry's growth, driven by regionalization and AI applications [41][43]